Transcriptomic Architecture of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Risk in Mexican Americans
Cells · 2026
DOI: 10.3390/cells15171592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Satish Kumar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, College of Sciences, McAllen, TX …. Hauptthemen laut MEDLINE: Mexican Americans, Transcriptome, Fatty Liver, Metabolic Diseases. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Hispanics of Mexican American descent in South Texas show a very high prevalence of MASLD, with some studies reporting rates as high as 50% in adults. However, assessment of genetic risk factors underlying this prevalence is complicated by a high co-occurrence of other metabolic disorders and variable endogenous and exogenous environmental risk factors. To map the transcriptomic architecture of MASLD hepatic steatosis risk, we conducted an epidemiological-scale investigation using human induced pluripotent stem cell (iPSC)-derived hepatocyte cultures from 193 participants in our longitudinal South Texas Family Study (STFS). iPSC-based models offer greater power to map genetic risk factors by experimentally controlling for confounding organismal and environmental factors. We combined transcriptome-wide gene expression analysis with high-content cellular measurements of neutral lipids to define a core hepatic steatosis MASLD phenotype at baseline (vehicle-treated) and following a lipid challenge. The additive genetic heritability of hepatic steatosis measures was 0.44 (p-value = 0.03) at baseline and 0.42 (p-value = 0.03) at post-lipid challenge. Multivariable linear regression comparing each gene’s expression against hepatic steatosis measures identified 1070 genes at baseline and 1229 genes post-lipid challenge, whose expression showed a transcriptome-wide statistically significant association (standardized |β| ≥ 0.24; Bonferroni-corrected p-value ≤ 0.001) with baseline and post-lipid challenge hepatic steatosis measures, respectively. Functional annotation and pathway enrichment analyses of these genes implicated a broad range of hepatocellular functions, mapping an overall transcriptomic architecture of MASLD-associated steatosis risk in Mexican Americans. The genes whose expression was positively correlated with hepatic steatosis measures suggest a direct role of variation in fatty acid (FA) and cholesterol uptake, de novo lipogenesis (DNL), and carbohydrate shunts in hepatic steatosis risk, as well as a cellular stress-associated and high-turnover metabolic state marked by elevated FA-oxidation and ketogenesis. In contrast, the genes whose expression was inversely correlated with hepatic steatosis measures suggest a significant role of the cellular cytoskeleton, hepatocyte epithelial integrity, and endosomal and autophagic clearance machinery in steatosis risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, College of Sciences, McAllen, TX 78504, USA.
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, College of Sciences, Brownsville, TX 78520, USA.
ORCID-Profile: Satish Kumar, Miriam Aceves, Tolulope Oluwadairo, Ana C Leandro, Juan Peralta, John Blangero
Förderung
- NIH HHS
- NIA NIH HHS
- NHLBI NIH HHS
- NCRR NIH HHS
- NHGRI NIH HHS
- NIGMS NIH HHS
- Valley Baptist Legacy Foundation
- NIH
Zitieren
APA
Kumar, S., Aceves, M., Guerra, L., Granados, J., Novilla, E., Juarez, F., Oluwadairo, T., Leandro, A. C., Leandro, M., Peralta, J., Williams-Blangero, S., Blangero, J., & Curran, J. E. (2026). Transcriptomic Architecture of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Risk in Mexican Americans. Cells. https://doi.org/10.3390/cells15171592
Vancouver
Kumar S, Aceves M, Guerra L, Granados J, Novilla E, Juarez F, et al. Transcriptomic Architecture of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Risk in Mexican Americans. Cells. 2026. doi:10.3390/cells15171592
BibTeX
@article{Kumar2026,
author = {Kumar, Satish and Aceves, Miriam and Guerra, Lorena and Granados, Jose and Novilla, Earl and Juarez, Felicia and Oluwadairo, Tolulope and Leandro, Ana C and Leandro, Marcelo and Peralta, Juan and Williams-Blangero, Sarah and Blangero, John and Curran, Joanne E},
title = {Transcriptomic Architecture of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Risk in Mexican Americans},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15171592}
}
EUVIMED